Medtronic Receives CE Mark for MiniMed 780G Insulin Pump to Treat Type 1 Diabetes

 Medtronic Receives CE Mark for MiniMed 780G Insulin Pump to Treat Type 1 Diabetes

Medtronic Receives CE Mark for MiniMed 780G Insulin Pump to Treat Type 1 Diabetes

Shots:

  • Medtronic has received CE Mark for its MiniMed 780G system, a closed-loop insulin pump designed to treat T1D patients aged 7-80 yrs. The system utilizes SmartGuard algorithm and stabilizes blood sugar levels and further improves glucose control
  • The MiniMed 780G system enables the personalization of glucose goals with an adjustable target setting as low as 100 mg/dL (5.5 mmol/L). The system automates the delivery of both basal insulin and correction boluses every 5mins. to help diabetic patients avoid highs and lows in blood sugar
  • Additionally, the Bluetooth connectivity of the system enables user’s real-time glucose data and trends on compatible iOS and Android smartphones via apps. The company expects to launch MiniMed 780G system in select European countries in H2’20

Click here to read full press release/ article | Ref: Medtronic | Image: Medtronic

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post